Experimental Ebola Vaccine Clears First-Stage of Testing

🔊 Listen to Post
Ebola has created a lot of news around the world and many leading medical companies are now working on introducing vaccines for it. According to the new study in the New England Journal of Medicine researchers have said that the new Ebola vaccine appears to be safe and has indicated signs of immune protection in the first stage test that involves 20 volunteers.

The vaccine is designed to spur the immune system’s production of anti-Ebola bodies. The report also claims that there are no serious side effects and that is great news as they are on the right track to come up with a new Ebola vaccine.

The new research report also claims that some of the patients that were given vaccine shots developed antibodies within four weeks to battle out Ebola virus. Currently, the virus has killed more than 5,600 people in West Africa in regions like Guinea, Liberia and Sierra Leone. The study focuses on developing virus fighting immune cells called T cells. The study was conducted on two different groups where one group received a higher dose shot that would eventually kill the Ebola virus internally. Many researchers believe that using the T cells for fighting Ebola is a promising factor.